Medication info

Liteset Extended Release Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›75mg / 1 tablet
Manufacturer / importer
Lightpharmtech Co., Ltd.
Appearance
Pale yellow elongated extended-release film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 201908030 · Approved 2019.11.21

This product's status changed to Expired on 2024.11.21. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults
Adult dose
Adults: The dose should be adjusted according to the patient's level of pain and response to treatment. An initial dose of 1 tablet is recommended. Thereafter, doses should be separated by at least 12 hours, and no more than 4 tablets should be taken per day. Do not use this drug for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this drug should be continued. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur during treatment; therefore, monitor the patient's response closely and adjust treatment appropriately. Elderly patients: Administer the usual adult dose. However, in patients aged 75 years or older, oral administration of tramadol increases its elimination half-life by 17%; therefore, administer this drug at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this drug have not been established in patients with renal impairment; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this drug have not been established in patients with hepatic impairment; therefore, its use is not recommended.

Ingredients

Manufacturer
Lightpharmtech Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient's level of pain and response to treatment. An initial dose of 1 tablet is recommended. Thereafter, doses should be separated by at least 12 hours, and no more than 4 tablets should be taken per day. Do not use this drug for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this drug should be continued. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur during treatment; therefore, monitor the patient's response closely and adjust treatment appropriately. Elderly patients: Administer the usual adult dose. However, in patients aged 75 years or older, oral administration of tramadol increases its elimination half-life by 17%; therefore, administer this drug at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this drug have not been established in patients with renal impairment; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this drug have not been established in patients with hepatic impairment; therefore, its use is not recommended.

Precautions

This medication may cause liver damage if taken by individuals who regularly consume more than three drinks a day, so it is essential to consult a doctor or pharmacist. If severe skin reactions such as rashes or blisters occur while taking this medication, discontinue use immediately and notify healthcare personnel. Since it contains tramadol, exceeding the recommended dosage may increase the risk of seizures, and the risk of seizures may also increase when taken with certain antidepressants or other central nervous system medications. Rarely, serious allergic reactions such as anaphylaxis may occur, so if symptoms such as difficulty breathing or hives develop, consult healthcare personnel immediately. Administering this medication to patients with severe asthma may complicate breathing; therefore, it should be provided in a facility equipped with medical equipment, and care should be taken with patients who have a risk of respiratory depression. Taking this medication with alcohol, sedatives, or sleeping pills, which are central nervous system depressants, can lead to severe drowsiness, respiratory depression, or coma; caution is necessary in such cases. Patients with head injuries or increased intracranial pressure should be specially monitored as this medication may further elevate brain pressure. It may cause dependence similar to opioid medications, so long-term use should be monitored for the potential of developing dependence. Patients with poor liver function should consult a doctor before using this medication, as one of its components, acetaminophen, may worsen liver damage. Some individuals may metabolize this medication at an unusually fast rate, which could lead to excessively strong effects, increasing the risk of respiratory depression, requiring caution. This medication should not be administered to children under 12 years old or to those below 18 years of age after certain surgeries, and adolescents aged 12 to 18 should also be avoided in the presence of risk factors. Elderly patients or those at risk of hyponatremia should periodically check for the occurrence of hyponatremia during administration of this medication. This medication should not be administered to individuals who are hypersensitive to its components or are experiencing central nervous system drug intoxication, severe respiratory depression, head injuries, or are taking MAO inhibitors. It is also prohibited for severely impaired patients of liver, kidney, or heart functions, nursing mothers, specific asthmatic patients, and patients with uncontrolled epilepsy. Abrupt discontinuation of this medication may result in withdrawal symptoms such as anxiety, insomnia, sweating, and nausea; therefore, the dosage should be gradually reduced according to the doctor’s instructions. Be careful as drowsiness or dizziness may occur while driving or operating machinery. In case of overdose, severe respiratory depression, liver damage, and seizures can occur, so immediate emergency measures should be taken, and professional medical assistance should be contacted.

Side effects

Liver damage, acute systemic pustular rash, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, weakness, fatigue, flushing, chest pain, stiffness, fainting, withdrawal symptoms, hypertension, exacerbation of hypertension, hypotension, arrhythmia, palpitations, tachycardia, dizziness, headache, tremors, ataxia, convulsions, hypertonia, migraine, exacerbation of migraine, involuntary muscle contractions, paresthesia, confusion, dizziness, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, dry mouth, nausea, vomiting, dysphagia, bloody stools, tongue swelling, decreased appetite, anxiety, confusion, euphoria, insomnia, nervous irritability, drowsiness, forgetfulness, depersonalization, depression, substance abuse, dependence, emotional instability, hallucinations, erectile dysfunction, nightmares, abnormal thought processes, anemia, breathlessness, proteinuria, urination disorders, oliguria, urinary retention, pruritus, rash, sweating, urticaria, abnormal liver function, weight loss, tinnitus, abnormal vision, chills, vasodilation, orthostatic hypotension, bradycardia, fatigue, myocardial ischemia, pulmonary edema, breathlessness, bronchospasm, wheezing, angioedema, allergic reactions, changes in appetite, exercise intolerance, respiratory depression, cognitive function abnormalities, difficulty concentrating, suicidal tendencies, hepatitis, liver failure, gastrointestinal bleeding, serotonin syndrome, exacerbation of asthma, withdrawal symptoms, delirium, miosis, mydriasis, speech disorders, movement disorders, hypoglycemia, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, thrombocytopenia, agranulocytosis, hypoprothrombinemia, leukoplakia, rhinitis, nasopharyngitis, limb pain, arthralgia, muscle cramps, muscle weakness, myalgia, blurred vision, conjunctivitis, reduced immune response, sensory abnormalities, stupor, taste abnormalities, involuntary muscle contractions, peripheral edema, pallor, blood pressure fluctuations, cough, runny nose, increased blood pressure, palpitations, irregular menstruation, breast cancer, injury, congestive heart failure, vertigo, confusion, dyspnea, bronchitis, frequent urination, abnormal kidney function tests, palpitations, aortic stenosis, bleeding, elevated cholesterol, hip pain, thigh pain, allergic rhinitis, nosebleeds, progression of biliary cancer, foreign body sensation in the eye, progression of liver cancer, cholecystitis, paralytic ileus, hiccups, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, drowsiness, insomnia, nervous irritability, hallucinations, depersonalization, decreased hemoglobin, reduced red blood cells, reduced white blood cells, increased white blood cells, decreased platelets, exacerbation of hypertension, aortic stenosis, nausea, vomiting, dyspepsia, abdominal pain, constipation, dry mouth, diarrhea, dysphagia, flatulence, tongue swelling, cold sweat, discomfort in the chest, facial edema, fever, weakness, hematuria, urinary retention, urinary incontinence, anuria, confusion, migraine, hypertonia, involuntary muscle contractions, convulsions, breathlessness, asthma, cough, bronchitis, urination disorders, urinary retention, frequent urination, abnormal kidney function tests, oliguria, pruritus, rash, increased sweating, urticaria, nausea, dizziness, headache, rash, pruritus, drowsiness, thirst, decreased appetite, insomnia, anxiety, depression, confusion, hallucinations, tinnitus, chills, weight loss, weakness, fever, chest pain, stiffness, fainting, withdrawal symptoms, hypoglycemia, hyponatremia, anaphylaxis, intentional overdose, myocardial infarction recurrence, hypotension, multiple organ failure, speech disorders, loss of consciousness, vomiting, confusion, stupor, migraine, dyspnea, vertigo, nausea, vomiting, lethargy, liver failure, renal tubular necrosis, coagulopathy, QT prolongation, somnolence, heart attack, death

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to avoid exposure to air or moisture. It is important to maintain storage at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Pale yellow elongated extended-release film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.